HomepageEarnings Events Newsdesk 6 days ago Johnson & Johnson (JNJ) TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years Johnson & Johnson (NYSE: JNJ) FY 2026 Other Release Autoliv, inc (ALV) Sec Form 8K » « TXNM Energy, Inc. (TXNM) FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure, Finds Transaction Consistent with Public Interest Newsdesk: